Several leading companies worldwide focus on the synthesis of complex pharmaceutical APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone Mesylate. These substances present significant challenges in process development due to their molecular sophistication. The manufacturers of these APIs often employ sophisticated processes and adhere